Navigation Links
Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
Date:4/3/2008

- Company to present interim results from phase 2 trial of novel compound

RX-1741 -

NEW HAVEN, Conn., April 3, 2008 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced that Albert Collinson, Ph.D., Chief Business Officer, will be presenting at the 10th Annual Superbugs & Superdrugs Conference on April 9, 2008 in London, UK. Dr. Collinson will disclose interim results from Rib-X's Phase 2 clinical trial of RX-1741 in the treatment of uncomplicated skin and soft tissue infections (uSSTI).

RX-1741 was discovered using Rib-X's proprietary computational tools and knowledge of the three dimensional structure of the 50S subunit of the ribosome. An oxazolidinone antibiotic that exhibits activity against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive organisms, RX-1741 has demonstrated both wider spectrum and stronger potency of activity than Zyvox(R) (linezolid), the only currently marketed product in this compound class.

uSSTI Study Design

The uSSTI study is a Phase 2, multicenter, randomized, open-label, comparative study to evaluate the safety and efficacy of RX-1741 versus linezolid in the outpatient treatment of adults with uSSTI. The study assesses the efficacy, safety and tolerability of a once or twice daily dose of RX-1741 compared to a twice-daily dose of linezolid. Dosing is given for five to ten days for the treatment of ambulatory patients with uSSTI.

The uSSTI study will enroll approximately 150 patients in study centers across the US. The Company intends to release final data from all patients during the first half of 2008.

About Rib-X Pharmaceuticals, Inc.

Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the st
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... , July 3, 2015 ... bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige Beteiligung ... zu haben. Mit dieser Übernahme dringt Lupin ... einem Umsatz von 765 Mrd. RUB im ... der Welt gehörte (IMS Health). Seit über ...
(Date:7/2/2015)... 2015 Pharma Major Lupin ... participación en ZAO "Biocom" en Rusia bajo ciertas ... de Lupin en el mercado farmacéutico de Rusia ... colocándolo como uno de los 10 principales mercados ... más de una década, el mercado farmacéutico ruso ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... 2, 2011 Cynosure, Inc. (NASDAQ: CYNO ), ... and non-invasive aesthetic applications, today announced that it will present ... (ET) on Thursday, June 9 in New York City. ... Davin and Executive Vice President, Treasurer and CFO Timothy Baker ...
... (NASDAQ: BNVI ), a pharmaceutical company focused on ... women,s health and cancer, today announced it will be presenting ... drug candidate for postmenopausal symptoms, Menerba ™ (also known ... World Congress on Menopause in Rome, Italy on June 11, ...
Cached Medicine Technology:Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 2Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 3Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 4
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... ... ... Smoothies are all the rage right now and all you need to make ... is proud to introduce a new line of all natural products that blend right ... , Aurora is offering a variety of blends and stand-alone items to choose from. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer ... week that he says will reveal biblical truth and expose popular lies regarding proper ... Bible Say Don’t Have Sex”, immediately goes into the core of the subject by ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was ... , The store, which opened July 1 at Duke’s Travel Plaza, is located at:, ...
(Date:7/2/2015)... ... July 02, 2015 , ... With summer in full swing, Americans are flocking to Canada’s ... the top spots for fishing in the world, and it’s easy to understand why. From ... has great fish. , Recreational fishing is a huge industry, and Americans make up ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... Nottingham are hoping to find out if inflammation of the ... condition which leads to pain, stiffness, swelling and disability. ... osteoarthritis in the knee. Now 200 patients, over the ... take part in a study led by research physiotherapist Michelle ...
... Network today announced that several leading commercial providers ... manufacturing sites with the network. SNM,s Clinical Trials ... need for streamlined drug discovery through the integration ... According to Michael M. Graham, M.D., Ph.D., SNM ...
... FORT WORTH, Texas and AUSTIN, Texas, July 23 RadioShack ... with seven-time Tour de France winner Lance Armstrong to form a new ... for Team RadioShack as a cyclist, runner and triathlete in events around ... , Lance Armstrong returned to the world stage of professional ...
... can be, experts say , THURSDAY, July 23 (HealthDay News) ... represents in the world of science is anything but that. ... Tiny,s brethren) marks a milestone in stem cell research: Healthy, ... not from embryonic cells, but rather cells sourced from adult ...
... , American Academy ... ROSEMONT, Ill., July 23 The American Academy of Orthopaedic ... organization dedicated to collecting and reporting on hip and knee joint replacement ... , , The goal of a ...
... and coronary function are restored , THURSDAY, JULY 23 ... heart tissue renew itself after a heart attack -- until ... blood to the heart become blocked, preventing enough oxygen from ... , But researchers at Children,s Hospital Boston report progress toward ...
Cached Medicine News:Health News:Detecting early signs of osteoarthritis 2Health News:SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 3Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 4Health News:Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice 2Health News:Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice 3Health News:American Joint Replacement Registry Announced 2Health News:Injection May Heal Damaged Heart 2
Inquire...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
Medicine Products: